论文部分内容阅读
在美国巨细胞病毒(CMV)仍然是引起先天性病毒感染和输血获得性感染(尤其是早产儿)的最重要的原因,且也是接受器官移植和其他免疫损害者发病的常见原因。抗病毒药物的不断发展,可有效地治疗一些CMV感染,但用化疗医治先天性感染,则不能指望有多大助益。由于原发妊娠感染有90%以上无症状,因此临床上不易发现。新生儿先天性感染的抗病毒治疗,似不能逆转在子宫内产生的损害。预防CMV感染,尤其是孕妇的CMV感染应是我们的主要目标。免疫接种已非常成功地预防了一些病毒感染,如天花,麻疹,流行性腮腺炎,脊髓灰质炎和风疹。目前,在美国先天性风疹感染已罕
In the United States, cytomegalovirus (CMV) remains the most important cause of congenital and blood transfusion-acquired infections, especially premature infants and is also a common cause of organ transplant and other immunocompromised infections. The continuous development of antiviral drugs can effectively treat some CMV infections, but chemotherapy can not cure the congenital infections, can not expect much help. As the primary pregnancy infection more than 90% of asymptomatic, clinically difficult to find. Antiviral treatment of neonatal congenital infection, it seems not to reverse the damage generated in the womb. Prevention of CMV infection, especially in pregnant women CMV infection should be our main goal. Vaccination has been very successful in preventing some viral infections, such as smallpox, measles, mumps, poliomyelitis and rubella. At present, congenital rubella infection is rare in the United States